Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial | Zendy

Seyyed Hamid Hashemi | Zendy; Latif Gachkar | Zendy; Fariba Keramat | Zendy; Mojgan Mamani | Zendy; Mehrdad Hajilooi | Zendy; Alireza Janbakhsh | Zendy; Mohammad Mehdi Majzoobi | Zendy; Hossein Mahjub | Zendy

Open Access

Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial

Author(s) -

Seyyed Hamid Hashemi,

Latif Gachkar,

Fariba Keramat,

Mojgan Mamani,

Mehrdad Hajilooi,

Alireza Janbakhsh,

Mohammad Mehdi Majzoobi,

Hossein Mahjub

Publication year - 2012

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2011.12.003

Subject(s) - medicine , doxycycline , brucellosis , streptomycin , rifampicin , ofloxacin , regimen , antibiotics , randomized controlled trial , gastroenterology , surgery , ciprofloxacin , immunology , tuberculosis , pathology , microbiology and biotechnology , biology

Traditional regimens for the treatment of brucellosis are associated with significant relapse rates. The aim of this study was to compare the efficacy of ofloxacin plus rifampin (OFX-RIF) versus doxycycline plus streptomycin (DOX-STR) and doxycycline plus rifampin (DOX-RIF) regimens in the treatment of brucellosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research